AbbVie Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Accounts-Payable" stands at 33.36 Billion United States Dollars as of 09/30/2025, the highest value at least since 03/31/2011, the period currently displayed.
As of the end of AbbVie Inc's third quarter, the item "Accounts Payable" stands at 33.36 Billion USD. This represents an increase of 4.81 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 9.75 percent compared to the value the year prior.
The 1 year change in percent is 9.75.
The 3 year change in percent is 42.64.
The 5 year change in percent is 71.93.
The 10 year change in percent is 314.69.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Accounts Payable | 905,699,262,464.00 |
![]() | Johnson & Johnson - Accounts Payable | 486,508,953,600.00 |
![]() | Roche Holding AG - Accounts Payable | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Accounts Payable | 280,205,508,085.11 |
![]() | Novartis AG - Accounts Payable | 255,096,620,580.91 |